150 related articles for article (PubMed ID: 11521772)
41. Effect of experience on judgments of adductor spasmodic dysphonia.
Eadie TL; Nicolici C; Baylor C; Almand K; Waugh P; Maronian N
Ann Otol Rhinol Laryngol; 2007 Sep; 116(9):695-701. PubMed ID: 17926593
[TBL] [Abstract][Full Text] [Related]
42. Listening: the key to diagnosing spasmodic dysphonia.
Braden MN; Hapner ER
ORL Head Neck Nurs; 2008; 26(1):8-12. PubMed ID: 18274236
[TBL] [Abstract][Full Text] [Related]
43. Posterior cricoarytenoid myoplasty with medialization thyroplasty in the management of refractory abductor spasmodic dysphonia.
Shaw GY; Sechtem PR; Rideout B
Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):303-6. PubMed ID: 12731624
[TBL] [Abstract][Full Text] [Related]
44. Adductor muscle activity abnormalities in abductor spasmodic dysphonia.
Cyrus CB; Bielamowicz S; Evans FJ; Ludlow CL
Otolaryngol Head Neck Surg; 2001 Jan; 124(1):23-30. PubMed ID: 11228447
[TBL] [Abstract][Full Text] [Related]
45. Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia.
Ludlow CL; Naunton RF; Sedory SE; Schulz GM; Hallett M
Neurology; 1988 Aug; 38(8):1220-5. PubMed ID: 3399071
[TBL] [Abstract][Full Text] [Related]
46. Vocal Parameters and Self-Perception in Individuals With Adductor Spasmodic Dysphonia.
Rojas GVE; Ricz H; Tumas V; Rodrigues GR; Toscano P; Aguiar-Ricz L
J Voice; 2017 May; 31(3):391.e7-391.e18. PubMed ID: 27866691
[TBL] [Abstract][Full Text] [Related]
47. Correlation of VHI-10 to voice laboratory measurements across five common voice disorders.
Gillespie AI; Gooding W; Rosen C; Gartner-Schmidt J
J Voice; 2014 Jul; 28(4):440-8. PubMed ID: 24698885
[TBL] [Abstract][Full Text] [Related]
48. Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia.
Adams SG; Hunt EJ; Irish JC; Charles DA; Lang AE; Durkin LC; Wong DL
J Otolaryngol; 1995 Dec; 24(6):345-51. PubMed ID: 8699600
[TBL] [Abstract][Full Text] [Related]
49. Procedures for the selection of spastic dysphonia patients for recurrent laryngeal nerve section.
Ludlow CL; Naunton RF; Bassich CJ
Otolaryngol Head Neck Surg; 1984 Feb; 92(1):24-31. PubMed ID: 6422412
[TBL] [Abstract][Full Text] [Related]
50. Abnormalities in long latency responses to superior laryngeal nerve stimulation in adductor spasmodic dysphonia.
Ludlow CL; Schulz GM; Yamashita T; Deleyiannis FW
Ann Otol Rhinol Laryngol; 1995 Dec; 104(12):928-35. PubMed ID: 7492063
[TBL] [Abstract][Full Text] [Related]
51. Outcomes assessment following treatment of spasmodic dysphonia with botulinum toxin.
Courey MS; Garrett CG; Billante CR; Stone RE; Portell MD; Smith TL; Netterville JL
Ann Otol Rhinol Laryngol; 2000 Sep; 109(9):819-22. PubMed ID: 11007083
[TBL] [Abstract][Full Text] [Related]
52. Longitudinal variations of laryngeal overpressure and voice-related quality of life in spasmodic dysphonia.
Yeung JC; Fung K; Davis E; Rai SK; Day AM; Dzioba A; Bornbaum C; Doyle PC
Laryngoscope; 2015 Mar; 125(3):661-6. PubMed ID: 25290557
[TBL] [Abstract][Full Text] [Related]
53. Influence of consonant voicing characteristics on sentence production in abductor versus adductor spasmodic dysphonia.
Cannito MP; Chorna LB; Kahane JC; Dworkin JP
J Voice; 2014 May; 28(3):394.e13-22. PubMed ID: 24440058
[TBL] [Abstract][Full Text] [Related]
54. Electroglottographic tracking of phonatory response to Botox.
Fisher KV; Scherer RC; Swank PR; Giddens C; Patten D
J Voice; 1999 Jun; 13(2):203-18. PubMed ID: 10442750
[TBL] [Abstract][Full Text] [Related]
55. Use of acupuncture for the treatment of adductor spasmodic dysphonia: a preliminary investigation.
Lee L; Daughton S; Scheer S; Stemple JC; Weinrich B; Miller-Seiler T; Goeller S; Levin L
J Voice; 2003 Sep; 17(3):411-24. PubMed ID: 14513964
[TBL] [Abstract][Full Text] [Related]
56. Reliability of the perceptual evaluation of adductor spasmodic dysphonia.
Chhetri DK; Merati AL; Blumin JH; Sulica L; Damrose EJ; Tsai VW
Ann Otol Rhinol Laryngol; 2008 Mar; 117(3):159-65. PubMed ID: 18444474
[TBL] [Abstract][Full Text] [Related]
57. Differential vibratory characteristics of adductor spasmodic dysphonia and muscle tension dysphonia on high-speed digital imaging.
Patel RR; Liu L; Galatsanos N; Bless DM
Ann Otol Rhinol Laryngol; 2011 Jan; 120(1):21-32. PubMed ID: 21370677
[TBL] [Abstract][Full Text] [Related]
58. Voice tuning with new instruments for type II thyroplasty in the treatment of adductor spasmodic dysphonia.
Sanuki T; Yumoto E; Toya Y; Kumai Y
Auris Nasus Larynx; 2016 Oct; 43(5):537-40. PubMed ID: 26811303
[TBL] [Abstract][Full Text] [Related]
59. Dynamic aspects of phonatory control in spasmodic dysphonia.
Ludlow CL; Connor NP
J Speech Hear Res; 1987 Jun; 30(2):197-206. PubMed ID: 3599951
[TBL] [Abstract][Full Text] [Related]
60. Speech intelligibility in severe adductor spasmodic dysphonia.
Bender BK; Cannito MP; Murry T; Woodson GE
J Speech Lang Hear Res; 2004 Feb; 47(1):21-32. PubMed ID: 15072525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
